Comparison of acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrations

TP53 aberrations are found in approximately 10% of patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) and are considered early driver events affecting leukemia stem cells. In this study, we compared features of a total of 84 patients with these disorders seen at a tertiar...

Descripción completa

Detalles Bibliográficos
Autores principales: Dutta, Sayantanee, Moritz, Jennifer, Pregartner, Gudrun, Thallinger, Gerhard G., Brandstätter, Ilona, Lind, Karin, Rezania, Simin, Lyssy, Freya, Reinisch, Andreas, Zebisch, Armin, Berghold, Andrea, Wölfler, Albert, Sill, Heinz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913568/
https://www.ncbi.nlm.nih.gov/pubmed/35083527
http://dx.doi.org/10.1007/s00277-022-04766-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913568/
https://www.ncbi.nlm.nih.gov/pubmed/35083527
http://dx.doi.org/10.1007/s00277-022-04766-2

Ejemplares similares